Introducing Mycobacteria
Published in Microbiology
Explore the Research
BioMed Central
Mycobacteria journal launch - Mycobacteria
Mycobacteria volume 1, Article number: 1 (2025) Cite this article
Mycobacterium tuberculosis complex (MTBC) diseases remain a significant public health concern, with Tuberculosis remaining one of the world’s most deadly diseases. Additionally, improvements in diagnostic techniques, increased surveillance, and ageing populations have contributed to rising cases of non-tuberculosis mycobacterial (NTM) diseases. These NTM diseases present significant treatment difficulties due to their inherent multidrug resistances and their burden is increasing globally.
Our hope is that this journal will provide a space for the mycobacteriology community to share any research that contributes to the eradication of mycobacterial diseases. Including but not limited to:
- clinical case histories
- epidemiology
- soil and environmental mycobacteriology
- human and animal research
- basic research and technologies
Professor Karen M Dobos, Editor in Chief, leads an international editorial board comprising of researchers with a wide range of expertise and experience. Prof. Dobos's research focuses on mass spectrometry approaches for identifying novel markers associated with early-tuberculosis disease events. She is currently a Professor of Microbiology, Immunology, and Pathology at Colorado State University and serves as the Scientific Director for the CSU Regional Biocontainment Laboratory and the Co-Director for the Mycobacteria Research Laboratories at CSU.
We invite researchers to submit their work for consideration. Waivers are available for articles submitted in 2025 and can be requested upon submission. Information regarding our submission guidelines is available on our website.
If you’re interested in joining the journal as an Editorial Board Member or reviewer, please reach out to us at: lewis.willer@springernature.com.
Collections and Calls for Papers
To stay at the forefront of mycobacteriology research, Mycobacteria has launched two new collections that are relevant to the field:
-
Biomarkers and Animal Models for Tuberculosis Research, Diagnosis and/or Treatment Monitoring
Aiming to enhance our understanding of TB diagnosis and treatment monitoring while fostering collaboration across disciplines to combat this global health challenge.
-
Combating Antibiotic Resistance and the Discovery and Development of Novel Therapeutics for Tuberculosis Control
Aiming to address the critical issues surrounding antibiotic resistance in Mycobacterium tuberculosis and the pursuit of novel therapeutic strategies.
Follow the Topic
-
Mycobacteria
This is a comprehensive, peer-reviewed publication focused on advancing mycobacterial research along with their practical applications.
Related Collections
With Collections, you can get published faster and increase your visibility.
Non-Tuberculous Mycobacteria - From Case Reports to Advances in Research and Discovery
Understanding non-tuberculous mycobacteria (NTM) is increasingly vital in the context of global health. As these organisms continue to emerge as significant pathogens, advancing our collective understanding in this area is crucial for both public health and clinical practices. Recent advances, including the identification of novel species and subspecies, insights into their pathogenic mechanisms, and the development of targeted therapies, highlight the progress we have made. However, many questions remain unanswered. Future research may unlock new diagnostic tools, innovative treatment strategies, and a better understanding of NTM ecology and epidemiology, which are essential for managing their impact on public health.
We invite researchers to contribute to this special Collection by submitting original research articles, reviews, and case studies. Topics of interest include, but are not limited to, the following:
• Epidemiology and clinical aspects of NTM diseases
• Environmental persistence of NTM and sources of transmission
• Advancements in diagnostics and biomarkers for NTM detection
• NTM physiology and pathogenic strategies
• Host immune responses to NTM infection
• Pre- and post-exposure NTM vaccines
• Therapeutic strategies and treatment challenges, including phage therapy, host-directed therapy and clinical trials
• Antimicrobial resistance patterns in NTM
• Unique case reports highlighting NTM infections in various populations
This Collection supports and amplifies research related to SDG 3, Good Health and Well-Being.
All submissions in this collection undergo the journal’s standard peer review process. Similarly, all manuscripts authored by a Guest Editor(s) will be handled by the Editor-in-Chief. As an open access publication, this journal levies an article processing fee (details here). We recognize that many key stakeholders may not have access to such resources and are committed to supporting participation in this issue wherever resources are a barrier. For more information about what support may be available, please visit OA funding and support, or email OAfundingpolicy@springernature.com or the Editor-in-Chief.
Publishing Model: Open Access
Deadline: Feb 23, 2026
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in